EAST RUTHERFORD, N.J., July 23, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that second quarter 2013 financial results will be released on Thursday, August 1, 2013 before the market opens.
The Company will host a conference call to discuss the financial results.
Second Quarter 2013 Earnings Conference Call
Thursday, August 1, 2013 at 8:30 a.m. Eastern Time
1-888-523-1225 for U.S.
1-719-325-2362 for International
1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Thursday, August 8, 2013
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation